Selected research
Market Outlook & Growth Opportunities
Global Single-Cell RNA Sequencing System Market Outlook and Growth Opportunities 2026
Market perspective
The global Single-Cell RNA Sequencing System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Single-Cell RNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Single-Cell RNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Single-Cell RNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Single-Cell RNA Sequencing System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Single-Cell RNA Sequencing System market include Standard BioTools Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., Dolomite Bio, Mission Bio, Inc., Scale Biosciences, Inc., SeqWell, Inc., Illumina, Inc. and Oxford Nanopore Technologies plc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Single-Cell RNA Sequencing System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Single-Cell RNA Sequencing System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Single-Cell RNA Sequencing System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single-Cell RNA Sequencing System market.
Single-Cell RNA Sequencing System Segment by Company
Standard BioTools Inc.
Takara Bio Inc.
Bio-Rad Laboratories, Inc.
Dolomite Bio
Mission Bio, Inc.
Scale Biosciences, Inc.
SeqWell, Inc.
Illumina, Inc.
Oxford Nanopore Technologies plc
Curio Bioscience, Inc.
Cellenion SAS
Singleron Biotechnologies Co., Ltd.
MGI Tech Co., Ltd.
SeekGene Bio-Sciences Co., Ltd.
MobiDrop Biotechnology Co., Ltd.
M20 Genomics Co., Ltd.
GeneMind Biosciences Co., Ltd.
CapitalBio Technology Co., Ltd.
Salus Biomed Co., Ltd.
Shanghai Wansheng Gene Tech Co., Ltd.
Shanghai Dapeng Bio-Tech Co., Ltd.
10x Genomics, Inc.
Parse Biosciences, Inc.
BD Biosciences (Becton, Dickinson and Company)
Single-Cell RNA Sequencing System Segment by Type
Droplet-Based System
Microwell-Based System
Microfluidic Chip-Based System
Single-Cell RNA Sequencing System Segment by Application
Cancer Research
Immunology Research
Developmental Biology Research
Other
Single-Cell RNA Sequencing System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Single-Cell RNA Sequencing System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Single-Cell RNA Sequencing System key companies, revenue, market share, and recent developments.
3. To split the Single-Cell RNA Sequencing System breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Single-Cell RNA Sequencing System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Single-Cell RNA Sequencing System significant trends, drivers, influence factors in global and regions.
6. To analyze Single-Cell RNA Sequencing System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-Cell RNA Sequencing System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single-Cell RNA Sequencing System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-Cell RNA Sequencing System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single-Cell RNA Sequencing System industry.
Chapter 3: Detailed analysis of Single-Cell RNA Sequencing System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Single-Cell RNA Sequencing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Single-Cell RNA Sequencing System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Droplet-Based System
- Microwell-Based System
- Microfluidic Chip-Based System
Applications
- Cancer Research
- Immunology Research
- Developmental Biology Research
- Other
Companies covered
- Standard BioTools Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- Dolomite Bio
- Mission Bio, Inc.
- Scale Biosciences, Inc.
- SeqWell, Inc.
- Illumina, Inc.
- Oxford Nanopore Technologies plc
- Curio Bioscience, Inc.
- Cellenion SAS
- Singleron Biotechnologies Co., Ltd.
- MGI Tech Co., Ltd.
- SeekGene Bio-Sciences Co., Ltd.
- MobiDrop Biotechnology Co., Ltd.
- M20 Genomics Co., Ltd.
- GeneMind Biosciences Co., Ltd.
- CapitalBio Technology Co., Ltd.
- Salus Biomed Co., Ltd.
- Shanghai Wansheng Gene Tech Co., Ltd.
- Shanghai Dapeng Bio-Tech Co., Ltd.
- 10x Genomics, Inc.
- Parse Biosciences, Inc.
- BD Biosciences (Becton, Dickinson and Company)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Single-Cell RNA Sequencing System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Single-Cell RNA Sequencing System Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Single-Cell RNA Sequencing System Market Dynamics
- 2.1 Single-Cell RNA Sequencing System Industry Trends
- 2.2 Single-Cell RNA Sequencing System Industry Drivers
- 2.3 Single-Cell RNA Sequencing System Industry Opportunities and Challenges
- 2.4 Single-Cell RNA Sequencing System Industry Restraints
3 Single-Cell RNA Sequencing System Market by Company
- 3.1 Global Single-Cell RNA Sequencing System Company Revenue Ranking in 2025
- 3.2 Global Single-Cell RNA Sequencing System Revenue by Company (2021-2026)
- 3.3 Global Single-Cell RNA Sequencing System Company Ranking (2024-2026)
- 3.4 Global Single-Cell RNA Sequencing System Company Manufacturing Base and Headquarters
- 3.5 Global Single-Cell RNA Sequencing System Company Product Type and Application
- 3.6 Global Single-Cell RNA Sequencing System Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Single-Cell RNA Sequencing System Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Single-Cell RNA Sequencing System Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Single-Cell RNA Sequencing System Market by Type
- 4.1 Single-Cell RNA Sequencing System Type Introduction
- 4.1.1 Droplet-Based System
- 4.1.2 Microwell-Based System
- 4.1.3 Microfluidic Chip-Based System
- 4.2 Global Single-Cell RNA Sequencing System Sales Value by Type
- 4.2.1 Global Single-Cell RNA Sequencing System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Single-Cell RNA Sequencing System Sales Value by Type (2021-2032)
- 4.2.3 Global Single-Cell RNA Sequencing System Sales Value Share by Type (2021-2032)
5 Single-Cell RNA Sequencing System Market by Application
- 5.1 Single-Cell RNA Sequencing System Application Introduction
- 5.1.1 Cancer Research
- 5.1.2 Immunology Research
- 5.1.3 Developmental Biology Research
- 5.1.4 Other
- 5.2 Global Single-Cell RNA Sequencing System Sales Value by Application
- 5.2.1 Global Single-Cell RNA Sequencing System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Single-Cell RNA Sequencing System Sales Value by Application (2021-2032)
- 5.2.3 Global Single-Cell RNA Sequencing System Sales Value Share by Application (2021-2032)
6 Single-Cell RNA Sequencing System Regional Value Analysis
- 6.1 Global Single-Cell RNA Sequencing System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Single-Cell RNA Sequencing System Sales Value by Region (2021-2032)
- 6.2.1 Global Single-Cell RNA Sequencing System Sales Value by Region: 2021-2026
- 6.2.2 Global Single-Cell RNA Sequencing System Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Single-Cell RNA Sequencing System Sales Value (2021-2032)
- 6.3.2 North America Single-Cell RNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Single-Cell RNA Sequencing System Sales Value (2021-2032)
- 6.4.2 Europe Single-Cell RNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Single-Cell RNA Sequencing System Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Single-Cell RNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Single-Cell RNA Sequencing System Sales Value (2021-2032)
- 6.6.2 South America Single-Cell RNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Single-Cell RNA Sequencing System Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Single-Cell RNA Sequencing System Sales Value Share by Country, 2025 VS 2032
7 Single-Cell RNA Sequencing System Country-level Value Analysis
- 7.1 Global Single-Cell RNA Sequencing System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Single-Cell RNA Sequencing System Sales Value by Country (2021-2032)
- 7.2.1 Global Single-Cell RNA Sequencing System Sales Value by Country (2021-2026)
- 7.2.2 Global Single-Cell RNA Sequencing System Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.7.2 France Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.14.2 China Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.17.2 India Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Single-Cell RNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Single-Cell RNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Single-Cell RNA Sequencing System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Standard BioTools Inc.
- 8.1.1 Standard BioTools Inc. Company Information
- 8.1.2 Standard BioTools Inc. Business Overview
- 8.1.3 Standard BioTools Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.1.4 Standard BioTools Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.1.5 Standard BioTools Inc. Recent Developments
- 8.2 Takara Bio Inc.
- 8.2.1 Takara Bio Inc. Company Information
- 8.2.2 Takara Bio Inc. Business Overview
- 8.2.3 Takara Bio Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.2.4 Takara Bio Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.2.5 Takara Bio Inc. Recent Developments
- 8.3 Bio-Rad Laboratories, Inc.
- 8.3.1 Bio-Rad Laboratories, Inc. Company Information
- 8.3.2 Bio-Rad Laboratories, Inc. Business Overview
- 8.3.3 Bio-Rad Laboratories, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio-Rad Laboratories, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.3.5 Bio-Rad Laboratories, Inc. Recent Developments
- 8.4 Dolomite Bio
- 8.4.1 Dolomite Bio Company Information
- 8.4.2 Dolomite Bio Business Overview
- 8.4.3 Dolomite Bio Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.4.4 Dolomite Bio Single-Cell RNA Sequencing System Product Portfolio
- 8.4.5 Dolomite Bio Recent Developments
- 8.5 Mission Bio, Inc.
- 8.5.1 Mission Bio, Inc. Company Information
- 8.5.2 Mission Bio, Inc. Business Overview
- 8.5.3 Mission Bio, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.5.4 Mission Bio, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.5.5 Mission Bio, Inc. Recent Developments
- 8.6 Scale Biosciences, Inc.
- 8.6.1 Scale Biosciences, Inc. Company Information
- 8.6.2 Scale Biosciences, Inc. Business Overview
- 8.6.3 Scale Biosciences, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.6.4 Scale Biosciences, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.6.5 Scale Biosciences, Inc. Recent Developments
- 8.7 SeqWell, Inc.
- 8.7.1 SeqWell, Inc. Company Information
- 8.7.2 SeqWell, Inc. Business Overview
- 8.7.3 SeqWell, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.7.4 SeqWell, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.7.5 SeqWell, Inc. Recent Developments
- 8.8 Illumina, Inc.
- 8.8.1 Illumina, Inc. Company Information
- 8.8.2 Illumina, Inc. Business Overview
- 8.8.3 Illumina, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.8.4 Illumina, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.8.5 Illumina, Inc. Recent Developments
- 8.9 Oxford Nanopore Technologies plc
- 8.9.1 Oxford Nanopore Technologies plc Company Information
- 8.9.2 Oxford Nanopore Technologies plc Business Overview
- 8.9.3 Oxford Nanopore Technologies plc Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.9.4 Oxford Nanopore Technologies plc Single-Cell RNA Sequencing System Product Portfolio
- 8.9.5 Oxford Nanopore Technologies plc Recent Developments
- 8.10 Curio Bioscience, Inc.
- 8.10.1 Curio Bioscience, Inc. Company Information
- 8.10.2 Curio Bioscience, Inc. Business Overview
- 8.10.3 Curio Bioscience, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.10.4 Curio Bioscience, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.10.5 Curio Bioscience, Inc. Recent Developments
- 8.11 Cellenion SAS
- 8.11.1 Cellenion SAS Company Information
- 8.11.2 Cellenion SAS Business Overview
- 8.11.3 Cellenion SAS Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.11.4 Cellenion SAS Single-Cell RNA Sequencing System Product Portfolio
- 8.11.5 Cellenion SAS Recent Developments
- 8.12 Singleron Biotechnologies Co., Ltd.
- 8.12.1 Singleron Biotechnologies Co., Ltd. Company Information
- 8.12.2 Singleron Biotechnologies Co., Ltd. Business Overview
- 8.12.3 Singleron Biotechnologies Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.12.4 Singleron Biotechnologies Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.12.5 Singleron Biotechnologies Co., Ltd. Recent Developments
- 8.13 MGI Tech Co., Ltd.
- 8.13.1 MGI Tech Co., Ltd. Company Information
- 8.13.2 MGI Tech Co., Ltd. Business Overview
- 8.13.3 MGI Tech Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.13.4 MGI Tech Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.13.5 MGI Tech Co., Ltd. Recent Developments
- 8.14 SeekGene Bio-Sciences Co., Ltd.
- 8.14.1 SeekGene Bio-Sciences Co., Ltd. Company Information
- 8.14.2 SeekGene Bio-Sciences Co., Ltd. Business Overview
- 8.14.3 SeekGene Bio-Sciences Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.14.4 SeekGene Bio-Sciences Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.14.5 SeekGene Bio-Sciences Co., Ltd. Recent Developments
- 8.15 MobiDrop Biotechnology Co., Ltd.
- 8.15.1 MobiDrop Biotechnology Co., Ltd. Company Information
- 8.15.2 MobiDrop Biotechnology Co., Ltd. Business Overview
- 8.15.3 MobiDrop Biotechnology Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.15.4 MobiDrop Biotechnology Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.15.5 MobiDrop Biotechnology Co., Ltd. Recent Developments
- 8.16 M20 Genomics Co., Ltd.
- 8.16.1 M20 Genomics Co., Ltd. Company Information
- 8.16.2 M20 Genomics Co., Ltd. Business Overview
- 8.16.3 M20 Genomics Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.16.4 M20 Genomics Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.16.5 M20 Genomics Co., Ltd. Recent Developments
- 8.17 GeneMind Biosciences Co., Ltd.
- 8.17.1 GeneMind Biosciences Co., Ltd. Company Information
- 8.17.2 GeneMind Biosciences Co., Ltd. Business Overview
- 8.17.3 GeneMind Biosciences Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.17.4 GeneMind Biosciences Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.17.5 GeneMind Biosciences Co., Ltd. Recent Developments
- 8.18 CapitalBio Technology Co., Ltd.
- 8.18.1 CapitalBio Technology Co., Ltd. Company Information
- 8.18.2 CapitalBio Technology Co., Ltd. Business Overview
- 8.18.3 CapitalBio Technology Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.18.4 CapitalBio Technology Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.18.5 CapitalBio Technology Co., Ltd. Recent Developments
- 8.19 Salus Biomed Co., Ltd.
- 8.19.1 Salus Biomed Co., Ltd. Company Information
- 8.19.2 Salus Biomed Co., Ltd. Business Overview
- 8.19.3 Salus Biomed Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.19.4 Salus Biomed Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.19.5 Salus Biomed Co., Ltd. Recent Developments
- 8.20 Shanghai Wansheng Gene Tech Co., Ltd.
- 8.20.1 Shanghai Wansheng Gene Tech Co., Ltd. Company Information
- 8.20.2 Shanghai Wansheng Gene Tech Co., Ltd. Business Overview
- 8.20.3 Shanghai Wansheng Gene Tech Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.20.4 Shanghai Wansheng Gene Tech Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.20.5 Shanghai Wansheng Gene Tech Co., Ltd. Recent Developments
- 8.21 Shanghai Dapeng Bio-Tech Co., Ltd.
- 8.21.1 Shanghai Dapeng Bio-Tech Co., Ltd. Company Information
- 8.21.2 Shanghai Dapeng Bio-Tech Co., Ltd. Business Overview
- 8.21.3 Shanghai Dapeng Bio-Tech Co., Ltd. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.21.4 Shanghai Dapeng Bio-Tech Co., Ltd. Single-Cell RNA Sequencing System Product Portfolio
- 8.21.5 Shanghai Dapeng Bio-Tech Co., Ltd. Recent Developments
- 8.22 10x Genomics, Inc.
- 8.22.1 10x Genomics, Inc. Company Information
- 8.22.2 10x Genomics, Inc. Business Overview
- 8.22.3 10x Genomics, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.22.4 10x Genomics, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.22.5 10x Genomics, Inc. Recent Developments
- 8.23 Parse Biosciences, Inc.
- 8.23.1 Parse Biosciences, Inc. Company Information
- 8.23.2 Parse Biosciences, Inc. Business Overview
- 8.23.3 Parse Biosciences, Inc. Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.23.4 Parse Biosciences, Inc. Single-Cell RNA Sequencing System Product Portfolio
- 8.23.5 Parse Biosciences, Inc. Recent Developments
- 8.24 BD Biosciences (Becton, Dickinson and Company)
- 8.24.1 BD Biosciences (Becton, Dickinson and Company) Company Information
- 8.24.2 BD Biosciences (Becton, Dickinson and Company) Business Overview
- 8.24.3 BD Biosciences (Becton, Dickinson and Company) Single-Cell RNA Sequencing System Revenue and Gross Margin (2021-2026)
- 8.24.4 BD Biosciences (Becton, Dickinson and Company) Single-Cell RNA Sequencing System Product Portfolio
- 8.24.5 BD Biosciences (Becton, Dickinson and Company) Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst